½ÃÀ庸°í¼­
»óǰÄÚµå
1709845

¼¼°èÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¼³Ä¡º°, ¸ð´Þ¸®Æ¼º°, À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, Àü¸Á ¹× ¿¹Ãø(2024-2031³â)

Global Stroke Post Processing Software Market Size, Share & Trends Analysis Report By Installation, By Modality (MRI, and CT Scan), By Type, By End-use, By Regional Outlook and Forecast, 2024 - 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: KBV Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 290 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 9.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³»°í 2031³â±îÁö 3¾ï 4,144¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ Å¬¶ó¿ìµå ¹× SaaS(Software-as-a-Service) ¼Ö·ç¼ÇÀº ºñ¿ë È¿À²¼º°ú È®À强À¸·Î ½ÃÀå¿¡¼­ Å« °ü½ÉÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ¿ÂÇÁ·¹¹Ì½º ¼ÒÇÁÆ®¿þ¾î¿Í´Â ´Þ¸® Ŭ¶ó¿ìµå ¼Ö·ç¼ÇÀ» Ȱ¿ëÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â °í¾×ÀÇ ÀÎÇÁ¶ó ÅõÀÚ ¾øÀÌ °í±Þ ³úÁ¹Áß À̹ÌÁö µµ±¸¿¡ ¿ø°ÝÀ¸·Î ¾×¼¼½ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â IT ¿¹»êÀÌ Á¦ÇÑµÈ º´¿ø¿¡ ƯÈ÷ À¯ÀÍÇϸç ÇÏÀÌ¿£µå AI¸¦ Ȱ¿ëÇÑ Áø´Ü ¼Ö·ç¼ÇÀ» µµÀÔÇÒ ¼ö ÀÖ½À´Ï´Ù. °á·ÐÀûÀ¸·Î Ŭ¶ó¿ìµå ¹× SaaSÇü ³úÁ¹Áß ÈÄó¸® ¼Ö·ç¼ÇÀÇ µµÀÔ È®´ë°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ´Ù°í ¸»ÇÒ ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù.

±×·¯³ª ½ÃÀåÀÇ ÁÖ¿ä °úÁ¦ Áß Çϳª´Â ÀÌ·¯ÇÑ °í±Þ ¼Ö·ç¼Ç°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀÔ´Ï´Ù. ƯÈ÷ °³¹ßµµ»óÁö¿ª¿¡¼­´Â ¸¹Àº Áß¼Ò±Ô¸ð ÀÇ·á±â°üÀÌ AI¸¦ Ȱ¿ëÇÑ ÈÄó¸® ¼ÒÇÁÆ®¿þ¾îÀÇ µµÀÔ¿¡ ÇÊ¿äÇÑ °í¾×ÀÇ ¶óÀ̼±½º, ÀÎÇÁ¶ó ¾÷±×·¹ÀÌµå ¹× À¯Áöº¸¼ö ºñ¿ëÀ» ºÎ´ãÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. Áï, ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾îÀÇ °íºñ¿ëÀº Áß¼Ò±Ô¸ðÀÇ ÀÇ·á±â°ü¿¡¼­ÀÇ µµÀÔÀ» Á¦ÇÑÇϰí ÀÖ´Â °ÍÀÔ´Ï´Ù.

¶ÇÇÑ, COVID-19 ÆÒµ¥¹ÍÀº ÁÖ·Î ¼¼°è ÇコÄÉ¾î ½Ã½ºÅÛÀÇ È¥¶õÀ¸·Î ÀÎÇØ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡ ¾Ç¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÆÒµ¥¹Í Áß ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ³úÁ¹Áß Áø´Ü°ú Ä¡·á Áö¿¬À¸·Î ÀÎÇØ °í±Þ À̹ÌÁö ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Å©°Ô ÁÙ¾îµé°í ½ÃÀå È®´ë°¡ Á¦ÇѵǾú½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

¼³Ä¡ Àü¸Á

¼³Ä¡ ¼ö¿¡ µû¶ó ½ÃÀåÀº µ¥½ºÅ©Åé°ú ÈÞ´ëÆù ¹× ÅÂºí¸´À¸·Î ºÐ·ùµË´Ï´Ù. ÈÞ´ëÆù ¹× ÅÂºí¸´ ºÎ¹®Àº 2023³â ½ÃÀåÀÇ 41% ¼öÀÍ Á¡À¯À²À» ¾ò¾ú½À´Ï´Ù. ¸ð¹ÙÀÏ ´ëÀÀÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î´Â È­»ó Áø´Ü °á°ú¿¡ÀÇ ½Å¼ÓÇÏ°í Æí¸®ÇÑ ¾×¼¼½º¸¦ °¡´ÉÇÏ°Ô ÇØ, ½Å°æ°ú Àǻ糪 ¹æ»ç¼±°ú Àǻ簡 ¿ø°ÝÀ¸·Î ³úÁ¹Áß Áõ·Ê¸¦ °ËÅäÇØ, º¸´Ù ½Å¼ÓÇÑ ÀÓ»ó ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖ°Ô ÇÕ´Ï´Ù.

¸ð´Þ¸®Æ¼ Àü¸Á

¸ð´Þ¸®Æ¼¸¦ ¹ÙÅÁÀ¸·Î ½ÃÀåÀº CT ½ºÄµ°ú MRI·Î ºÐ·ùµË´Ï´Ù. CT ½ºÄµ ºÎ¹®Àº 2023³â ½ÃÀå ¼öÀÍ Á¡À¯À²ÀÇ 32%¸¦ ±â·ÏÇß½À´Ï´Ù. ƯÈ÷ ÃâÇ÷¼º ³úÁ¹ÁßÀÇ °ËÃâ¿¡ À־, ½Å¼ÓÇÑ ³úÁ¹Áß Æò°¡¸¦ À§ÇÑ AI °­È­ CT È­»ó Áø´Ü ¼ÒÇÁÆ®¿þ¾îÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ, ÀÌ ºÎ¹® ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¼³Ä¡ Àü¸Á

½ÃÀåÀº À¯Çüº°·Î ÇãÇ÷¼º ³úÁ¹Áß, ÃâÇ÷¼º ³úÁ¹Áß µîÀ¸·Î ºÐ·ùµË´Ï´Ù. ÃâÇ÷¼º ³úÁ¹Áß ºÎ¹®Àº 2023³â ½ÃÀåÀÇ 11% ¼öÀÍ °øÀ¯¸¦ ȹµæÇß½À´Ï´Ù. Àû½Ã¿¡ ÀÇ·á °³ÀÔÀ» °¡´ÉÇϰÔÇÏ´Â ¿ä±¸ Áõ°¡¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀº º´¿ø, Ŭ¸®´Ð, Àü¹®¼¾ÅÍ µîÀ¸·Î ºÐ·ùµË´Ï´Ù. Àü¹®¼¾ÅÍ ºÎ¹®Àº 2023³â ½ÃÀå Á¡À¯À²ÀÇ 26%¸¦ ȹµæÇß½À´Ï´Ù. Àü¿ë ³úÁ¹Áß Ä¡·á ½Ã¼³¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Àü¹®¼¾ÅÍ¿ëÀ¸·Î Ä¿½ºÅ͸¶ÀÌÁîµÈ AI ±¸µ¿Çü È­»ó Áø´Ü ¼Ö·ç¼ÇÀÇ Áøº¸¿¡ ÀÇÇØ ÀÌ ºÎ¹®¿¡ À־ÀÇ ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾îÀÇ Ã¤¿ëÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î º¼ ¶§ ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(LAMEA)¿¡¼­ ºÐ¼®µÇ°í ÀÖ½À´Ï´Ù. AI ±â¹Ý ÀÇ·á ¿µ»ó ¼Ö·ç¼Ç µµÀÔ È®´ë, ³úÁ¹Áß ¿¹¹æ¿¡ ´ëÇÑ ÀǽÄÀÇ ³ô¾ÆÁü, ±×¸®°í ³úÁ¹ÁßÀÇ Áø´Ü°ú Ä¡·á¿¡ ´ëÇÑ À¯¸®ÇÑ »óȯ Á¤Ã¥¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å°æÀ̹ÌÁö ±â¼úÀÇ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß°ú, ÀÇ·á±â°ü°ú ¼ÒÇÁÆ®¿þ¾î ÇÁ·Î¹ÙÀÌ´õ¿ÍÀÇ Á¦ÈÞ°¡, À¯·´¿¡¼­ ½ÃÀå È®´ë¸¦ ÁöÁöÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ¸ñÀû
  • ½ÃÀå ¹üÀ§
  • ¼¼ºÐÈ­
  • Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå °³°ü

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

  • ¼­·Ð
    • °³¿ä
      • ½ÃÀ屸¼º°ú ½Ã³ª¸®¿À
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
    • ½ÃÀå °úÁ¦

Á¦4Àå °æÀï ºÐ¼®- ¼¼°è

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ÀÇ ÃÖ±Ù Àü·«
  • Porter's Five Forces ºÐ¼®

Á¦5Àå ¼¼°è ½ÃÀå : ¼³Ä¡º°

  • ¼¼°è µ¥½ºÅ©Åé ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÈÞ´ëÀüÈ­ ¹× ÅÂºí¸´ ½ÃÀå : Áö¿ªº°

Á¦6Àå ¼¼°è ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ¼¼°èÀÇ MRI ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ CT ½ºÄµ ½ÃÀå : Áö¿ªº°

Á¦7Àå ¼¼°è ½ÃÀå : À¯Çüº°

  • ¼¼°èÀÇ ÇãÇ÷¼º ³úÁ¹Áß ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÃâÇ÷¼º ³úÁ¹Áß ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ±âŸ À¯Çü ½ÃÀå : Áö¿ªº°

Á¦8Àå ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¼¼°èÀÇ º´¿ø ¹× Áø·á¼Ò ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ Àü¹®¼¾ÅÍ ¹× ±âŸ ½ÃÀå : Áö¿ªº°

Á¦9Àå ¼¼°è ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ºÏ¹Ì ½ÃÀå : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
      • ±âŸ ºÏ¹Ì
  • À¯·´
    • À¯·´ ½ÃÀå : ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ·¯½Ã¾Æ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • Çѱ¹
      • È£ÁÖ
      • ¸»·¹À̽þÆ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿¡¤¾ÆÇÁ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿¡¤¾ÆÇÁ¸®Ä« ½ÃÀå : ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä«
      • ³ªÀÌÁö¸®¾Æ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿¡¤¾ÆÇÁ¸®Ä«

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Brainomix Limited
  • Vizai, Inc.
  • GE HealthCare Technologies, Inc
  • Siemens Healthineers AG(Siemens AG)
  • Koninklijke Philips NV
  • Canon, Inc(Canon Medical Systems Corporation)
  • Terarecon, Inc
  • Nicolab BV
  • Medtronic PLC
  • iSchemaView Inc(RapidAI)

Á¦11Àå ³úÁ¹Áß ÈÄó¸® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

KTH

The Global Stroke Post Processing Software Market size is expected to reach $341.44 million by 2031, rising at a market growth of 9.2% CAGR during the forecast period.

The North America segment recorded 44% revenue share in the market in 2023. The region's dominance can be attributed to the high prevalence of stroke cases, advanced healthcare infrastructure, and significant investments in medical imaging and AI-driven diagnostic tools. Additionally, the presence of major market players and supportive government initiatives for stroke management and early detection have further contributed to the market's growth in North America.

The increasing focus on early stroke detection has led to various awareness campaigns and training initiatives worldwide. Governments, healthcare organizations, and non-profit agencies actively promote education programs for healthcare professionals and the general public. These initiatives emphasize recognizing stroke symptoms quickly and ensuring immediate medical intervention, significantly improving patient outcomes. In conclusion, raising awareness and training initiatives for early stroke detection and management propel the market's growth.

Additionally, Cloud-based and Software-as-a-Service (SaaS) solutions are gaining significant traction in the market due to their cost-effectiveness and scalability. Unlike traditional on-premise software, cloud-based solutions allow healthcare providers to access advanced stroke imaging tools remotely without investing in expensive infrastructure. This shift is particularly beneficial for hospitals with limited IT budgets, enabling them to adopt high-end AI-powered diagnostic solutions. In conclusion, the growing adoption of cloud-based and SaaS stroke post-processing solutions drives the market's growth.

However, One of the primary challenges in the market is the high cost associated with these advanced solutions. Many small and medium-sized healthcare facilities, particularly in developing regions, struggle to afford the expensive licenses, infrastructure upgrades, and maintenance costs required to implement AI-driven post-processing software. In conclusion, the high cost of stroke post-processing software limits adoption among small and medium healthcare facilities.

Moreover, The COVID-19 pandemic had a negative impact on the Stroke Post Processing Software Market, primarily due to disruptions in healthcare systems worldwide. Many hospitals and medical facilities prioritized COVID-19 treatment, leading to a decline in stroke-related diagnostic procedures and elective imaging services. As a result, the demand for stroke post-processing software declined, affecting market growth during the pandemic. The delay in stroke diagnosis and treatment significantly reduced the need for advanced imaging solutions, limiting the market's expansion. Additionally, the shift of resources towards pandemic response led to a slowdown in research and development activities in stroke imaging software. Thus, the COVID-19 pandemic had a negative impact on the market.

Installation Outlook

Based on installation, the market is characterized into desktop and mobile phones & tablets. The mobile phones & tablets segment procured 41% revenue share in the market in 2023. The increasing demand for mobile-based healthcare solutions, driven by the need for remote stroke assessment and telemedicine integration, has fueled growth in this segment. Mobile-friendly stroke post-processing software enables quick and convenient access to imaging results, allowing neurologists and radiologists to review stroke cases remotely and make faster clinical decisions.

Modality Outlook

On the basis of modality, the market is classified into CT scan and MRI. The CT scan segment recorded 32% revenue share in the market in 2023. CT scans remain a crucial modality for stroke diagnosis due to their rapid imaging capabilities, making them the preferred choice in emergency settings. The increasing adoption of AI-enhanced CT imaging software for quick stroke assessment, especially in detecting hemorrhagic strokes, has driven market growth in this segment.

Type Outlook

By type, the market is divided into ischemic stroke, hemorrhagic stroke, and others. The hemorrhagic stroke segment garnered 11% revenue share in the market in 2023. This growth can be attributed to the increasing need for precise and rapid identification of brain hemorrhages, enabling timely medical interventions. Advanced imaging software solutions that assist in differentiating hemorrhagic stroke subtypes and improving diagnostic accuracy have seen rising adoption.

End-use Outlook

Based on end use, the market is segmented into hospitals & clinics, specialty centers, and others. The specialty centers segment acquired 26% revenue share in the market in 2023. These centers are crucial in providing specialized stroke care, rehabilitation, and advanced neuroimaging services, contributing to their market expansion. The growing demand for dedicated stroke treatment facilities and advancements in AI-driven imaging solutions tailored for specialty centers has enhanced the adoption of stroke post-processing software in this segment.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment witnessed 28% revenue share in the market in 2023. The region's strong performance is driven by the increasing adoption of AI-based medical imaging solutions, rising awareness about stroke prevention, and favorable reimbursement policies for stroke diagnosis and treatment. Additionally, ongoing research and development in neuroimaging technologies and collaborations between healthcare institutions and software providers have supported market expansion in Europe.

Recent Strategies Deployed in the Market

  • 2025-Feb: Koninklijke Philips N.V. announced the partnership with the World Bank and Ukraine's Ministry of Health, which is modernizing stroke care in Ukraine by deploying 25 Azurion interventional suites. With 19 installed, the initiative enhances neurovascular treatments and physician training, addressing rising stroke cases amid war-related healthcare challenges.
  • 2025-Feb: Medtronic PLC collaborates with Brainomix to integrate AI-powered stroke detection into its neurovascular portfolio. Brainomix's e-Stroke platform enhances stroke diagnosis and treatment decisions. This collaboration aims to improve patient outcomes by enabling faster, more accurate stroke assessments, and strengthening Medtronic's position in AI-driven stroke care solutions.
  • 2024-Mar: Viz.ai, Inc. teamed up with Medtronic to enhance post-acute stroke care in the U.S., focusing on cryptogenic stroke patients. Their collaboration aims to improve cardiology follow-ups, reducing the risk of secondary strokes by ensuring timely and necessary care for better patient outcomes.
  • 2022-Jan: Brainomix Limited unveiled e-Stroke 11 the latest version of its award-winning AI-based stroke imaging platform that is expected to enhance communication within stroke networks by facilitating quick and secure access, review, and sharing of images and patient data as well as sending messages, making calls directly from e-Stroke Mobile App and tagging patients for thrombectomy eligibility - all designed for further workflow optimization which would facilitate quicker transfer and treatment decisions.
  • 2021-Jul: Brainomix Limited unveiled its AI-powered stroke software in Poland as part of the POLKARD initiative. The launch aims to enhance stroke diagnosis and treatment by leveraging artificial intelligence. This initiative supports improved healthcare outcomes and faster decision-making in stroke management across Polish hospitals.

List of Key Companies Profiled

  • Brainomix Limited
  • Viz.ai, Inc.
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Koninklijke Philips N.V.
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Terarecon, Inc.
  • Nicolab B.V.
  • Medtronic PLC
  • iSchemaView Inc. (RapidAI)

Global Stroke Post Processing Software Market Report Segmentation

By Installation

  • Desktop
  • Mobile Phones & Tablets

By Modality

  • MRI
  • CT Scan

By Type

  • Ischemic Stroke
  • Hemorrhagic Stroke
  • Other Type

By End-use

  • Hospitals & Clinics
  • Specialty Centers & Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Stroke Post Processing Software Market, by Installation
    • 1.4.2 Global Stroke Post Processing Software Market, by Modality
    • 1.4.3 Global Stroke Post Processing Software Market, by Type
    • 1.4.4 Global Stroke Post Processing Software Market, by End-use
    • 1.4.5 Global Stroke Post Processing Software Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 Market Share Analysis, 2023
  • 4.2 Recent Strategies Deployed in Stroke Post Processing Software Market
  • 4.3 Porter Five Forces Analysis

Chapter 5. Global Stroke Post Processing Software Market by Installation

  • 5.1 Global Desktop Market by Region
  • 5.2 Global Mobile Phones & Tablets Market by Region

Chapter 6. Global Stroke Post Processing Software Market by Modality

  • 6.1 Global MRI Market by Region
  • 6.2 Global CT Scan Market by Region

Chapter 7. Global Stroke Post Processing Software Market by Type

  • 7.1 Global Ischemic Stroke Market by Region
  • 7.2 Global Hemorrhagic Stroke Market by Region
  • 7.3 Global Other Type Market by Region

Chapter 8. Global Stroke Post Processing Software Market by End-use

  • 8.1 Global Hospitals & Clinics Market by Region
  • 8.2 Global Specialty Centers & Others Market by Region

Chapter 9. Global Stroke Post Processing Software Market by Region

  • 9.1 North America Stroke Post Processing Software Market
    • 9.1.1 North America Stroke Post Processing Software Market by Installation
      • 9.1.1.1 North America Desktop Market by Region
      • 9.1.1.2 North America Mobile Phones & Tablets Market by Region
    • 9.1.2 North America Stroke Post Processing Software Market by Modality
      • 9.1.2.1 North America MRI Market by Country
      • 9.1.2.2 North America CT Scan Market by Country
    • 9.1.3 North America Stroke Post Processing Software Market by Type
      • 9.1.3.1 North America Ischemic Stroke Market by Country
      • 9.1.3.2 North America Hemorrhagic Stroke Market by Country
      • 9.1.3.3 North America Other Type Market by Country
    • 9.1.4 North America Stroke Post Processing Software Market by End-use
      • 9.1.4.1 North America Hospitals & Clinics Market by Country
      • 9.1.4.2 North America Specialty Centers & Others Market by Country
    • 9.1.5 North America Stroke Post Processing Software Market by Country
      • 9.1.5.1 US Stroke Post Processing Software Market
        • 9.1.5.1.1 US Stroke Post Processing Software Market by Installation
        • 9.1.5.1.2 US Stroke Post Processing Software Market by Modality
        • 9.1.5.1.3 US Stroke Post Processing Software Market by Type
        • 9.1.5.1.4 US Stroke Post Processing Software Market by End-use
      • 9.1.5.2 Canada Stroke Post Processing Software Market
        • 9.1.5.2.1 Canada Stroke Post Processing Software Market by Installation
        • 9.1.5.2.2 Canada Stroke Post Processing Software Market by Modality
        • 9.1.5.2.3 Canada Stroke Post Processing Software Market by Type
        • 9.1.5.2.4 Canada Stroke Post Processing Software Market by End-use
      • 9.1.5.3 Mexico Stroke Post Processing Software Market
        • 9.1.5.3.1 Mexico Stroke Post Processing Software Market by Installation
        • 9.1.5.3.2 Mexico Stroke Post Processing Software Market by Modality
        • 9.1.5.3.3 Mexico Stroke Post Processing Software Market by Type
        • 9.1.5.3.4 Mexico Stroke Post Processing Software Market by End-use
      • 9.1.5.4 Rest of North America Stroke Post Processing Software Market
        • 9.1.5.4.1 Rest of North America Stroke Post Processing Software Market by Installation
        • 9.1.5.4.2 Rest of North America Stroke Post Processing Software Market by Modality
        • 9.1.5.4.3 Rest of North America Stroke Post Processing Software Market by Type
        • 9.1.5.4.4 Rest of North America Stroke Post Processing Software Market by End-use
  • 9.2 Europe Stroke Post Processing Software Market
    • 9.2.1 Europe Stroke Post Processing Software Market by Installation
      • 9.2.1.1 Europe Desktop Market by Country
      • 9.2.1.2 Europe Mobile Phones & Tablets Market by Country
    • 9.2.2 Europe Stroke Post Processing Software Market by Modality
      • 9.2.2.1 Europe MRI Market by Country
      • 9.2.2.2 Europe CT Scan Market by Country
    • 9.2.3 Europe Stroke Post Processing Software Market by Type
      • 9.2.3.1 Europe Ischemic Stroke Market by Country
      • 9.2.3.2 Europe Hemorrhagic Stroke Market by Country
      • 9.2.3.3 Europe Other Type Market by Country
    • 9.2.4 Europe Stroke Post Processing Software Market by End-use
      • 9.2.4.1 Europe Hospitals & Clinics Market by Country
      • 9.2.4.2 Europe Specialty Centers & Others Market by Country
    • 9.2.5 Europe Stroke Post Processing Software Market by Country
      • 9.2.5.1 Germany Stroke Post Processing Software Market
        • 9.2.5.1.1 Germany Stroke Post Processing Software Market by Installation
        • 9.2.5.1.2 Germany Stroke Post Processing Software Market by Modality
        • 9.2.5.1.3 Germany Stroke Post Processing Software Market by Type
        • 9.2.5.1.4 Germany Stroke Post Processing Software Market by End-use
      • 9.2.5.2 UK Stroke Post Processing Software Market
        • 9.2.5.2.1 UK Stroke Post Processing Software Market by Installation
        • 9.2.5.2.2 UK Stroke Post Processing Software Market by Modality
        • 9.2.5.2.3 UK Stroke Post Processing Software Market by Type
        • 9.2.5.2.4 UK Stroke Post Processing Software Market by End-use
      • 9.2.5.3 France Stroke Post Processing Software Market
        • 9.2.5.3.1 France Stroke Post Processing Software Market by Installation
        • 9.2.5.3.2 France Stroke Post Processing Software Market by Modality
        • 9.2.5.3.3 France Stroke Post Processing Software Market by Type
        • 9.2.5.3.4 France Stroke Post Processing Software Market by End-use
      • 9.2.5.4 Russia Stroke Post Processing Software Market
        • 9.2.5.4.1 Russia Stroke Post Processing Software Market by Installation
        • 9.2.5.4.2 Russia Stroke Post Processing Software Market by Modality
        • 9.2.5.4.3 Russia Stroke Post Processing Software Market by Type
        • 9.2.5.4.4 Russia Stroke Post Processing Software Market by End-use
      • 9.2.5.5 Spain Stroke Post Processing Software Market
        • 9.2.5.5.1 Spain Stroke Post Processing Software Market by Installation
        • 9.2.5.5.2 Spain Stroke Post Processing Software Market by Modality
        • 9.2.5.5.3 Spain Stroke Post Processing Software Market by Type
        • 9.2.5.5.4 Spain Stroke Post Processing Software Market by End-use
      • 9.2.5.6 Italy Stroke Post Processing Software Market
        • 9.2.5.6.1 Italy Stroke Post Processing Software Market by Installation
        • 9.2.5.6.2 Italy Stroke Post Processing Software Market by Modality
        • 9.2.5.6.3 Italy Stroke Post Processing Software Market by Type
        • 9.2.5.6.4 Italy Stroke Post Processing Software Market by End-use
      • 9.2.5.7 Rest of Europe Stroke Post Processing Software Market
        • 9.2.5.7.1 Rest of Europe Stroke Post Processing Software Market by Installation
        • 9.2.5.7.2 Rest of Europe Stroke Post Processing Software Market by Modality
        • 9.2.5.7.3 Rest of Europe Stroke Post Processing Software Market by Type
        • 9.2.5.7.4 Rest of Europe Stroke Post Processing Software Market by End-use
  • 9.3 Asia Pacific Stroke Post Processing Software Market
    • 9.3.1 Asia Pacific Stroke Post Processing Software Market by Installation
      • 9.3.1.1 Asia Pacific Desktop Market by Country
      • 9.3.1.2 Asia Pacific Mobile Phones & Tablets Market by Country
    • 9.3.2 Asia Pacific Stroke Post Processing Software Market by Modality
      • 9.3.2.1 Asia Pacific MRI Market by Country
      • 9.3.2.2 Asia Pacific CT Scan Market by Country
    • 9.3.3 Asia Pacific Stroke Post Processing Software Market by Type
      • 9.3.3.1 Asia Pacific Ischemic Stroke Market by Country
      • 9.3.3.2 Asia Pacific Hemorrhagic Stroke Market by Country
      • 9.3.3.3 Asia Pacific Other Type Market by Country
    • 9.3.4 Asia Pacific Stroke Post Processing Software Market by End-use
      • 9.3.4.1 Asia Pacific Hospitals & Clinics Market by Country
      • 9.3.4.2 Asia Pacific Specialty Centers & Others Market by Country
    • 9.3.5 Asia Pacific Stroke Post Processing Software Market by Country
      • 9.3.5.1 China Stroke Post Processing Software Market
        • 9.3.5.1.1 China Stroke Post Processing Software Market by Installation
        • 9.3.5.1.2 China Stroke Post Processing Software Market by Modality
        • 9.3.5.1.3 China Stroke Post Processing Software Market by Type
        • 9.3.5.1.4 China Stroke Post Processing Software Market by End-use
      • 9.3.5.2 Japan Stroke Post Processing Software Market
        • 9.3.5.2.1 Japan Stroke Post Processing Software Market by Installation
        • 9.3.5.2.2 Japan Stroke Post Processing Software Market by Modality
        • 9.3.5.2.3 Japan Stroke Post Processing Software Market by Type
        • 9.3.5.2.4 Japan Stroke Post Processing Software Market by End-use
      • 9.3.5.3 India Stroke Post Processing Software Market
        • 9.3.5.3.1 India Stroke Post Processing Software Market by Installation
        • 9.3.5.3.2 India Stroke Post Processing Software Market by Modality
        • 9.3.5.3.3 India Stroke Post Processing Software Market by Type
        • 9.3.5.3.4 India Stroke Post Processing Software Market by End-use
      • 9.3.5.4 South Korea Stroke Post Processing Software Market
        • 9.3.5.4.1 South Korea Stroke Post Processing Software Market by Installation
        • 9.3.5.4.2 South Korea Stroke Post Processing Software Market by Modality
        • 9.3.5.4.3 South Korea Stroke Post Processing Software Market by Type
        • 9.3.5.4.4 South Korea Stroke Post Processing Software Market by End-use
      • 9.3.5.5 Australia Stroke Post Processing Software Market
        • 9.3.5.5.1 Australia Stroke Post Processing Software Market by Installation
        • 9.3.5.5.2 Australia Stroke Post Processing Software Market by Modality
        • 9.3.5.5.3 Australia Stroke Post Processing Software Market by Type
        • 9.3.5.5.4 Australia Stroke Post Processing Software Market by End-use
      • 9.3.5.6 Malaysia Stroke Post Processing Software Market
        • 9.3.5.6.1 Malaysia Stroke Post Processing Software Market by Installation
        • 9.3.5.6.2 Malaysia Stroke Post Processing Software Market by Modality
        • 9.3.5.6.3 Malaysia Stroke Post Processing Software Market by Type
        • 9.3.5.6.4 Malaysia Stroke Post Processing Software Market by End-use
      • 9.3.5.7 Rest of Asia Pacific Stroke Post Processing Software Market
        • 9.3.5.7.1 Rest of Asia Pacific Stroke Post Processing Software Market by Installation
        • 9.3.5.7.2 Rest of Asia Pacific Stroke Post Processing Software Market by Modality
        • 9.3.5.7.3 Rest of Asia Pacific Stroke Post Processing Software Market by Type
        • 9.3.5.7.4 Rest of Asia Pacific Stroke Post Processing Software Market by End-use
  • 9.4 LAMEA Stroke Post Processing Software Market
    • 9.4.1 LAMEA Stroke Post Processing Software Market by Installation
      • 9.4.1.1 LAMEA Desktop Market by Country
      • 9.4.1.2 LAMEA Mobile Phones & Tablets Market by Country
    • 9.4.2 LAMEA Stroke Post Processing Software Market by Modality
      • 9.4.2.1 LAMEA MRI Market by Country
      • 9.4.2.2 LAMEA CT Scan Market by Country
    • 9.4.3 LAMEA Stroke Post Processing Software Market by Type
      • 9.4.3.1 LAMEA Ischemic Stroke Market by Country
      • 9.4.3.2 LAMEA Hemorrhagic Stroke Market by Country
      • 9.4.3.3 LAMEA Other Type Market by Country
    • 9.4.4 LAMEA Stroke Post Processing Software Market by End-use
      • 9.4.4.1 LAMEA Hospitals & Clinics Market by Country
      • 9.4.4.2 LAMEA Specialty Centers & Others Market by Country
    • 9.4.5 LAMEA Stroke Post Processing Software Market by Country
      • 9.4.5.1 Brazil Stroke Post Processing Software Market
        • 9.4.5.1.1 Brazil Stroke Post Processing Software Market by Installation
        • 9.4.5.1.2 Brazil Stroke Post Processing Software Market by Modality
        • 9.4.5.1.3 Brazil Stroke Post Processing Software Market by Type
        • 9.4.5.1.4 Brazil Stroke Post Processing Software Market by End-use
      • 9.4.5.2 Argentina Stroke Post Processing Software Market
        • 9.4.5.2.1 Argentina Stroke Post Processing Software Market by Installation
        • 9.4.5.2.2 Argentina Stroke Post Processing Software Market by Modality
        • 9.4.5.2.3 Argentina Stroke Post Processing Software Market by Type
        • 9.4.5.2.4 Argentina Stroke Post Processing Software Market by End-use
      • 9.4.5.3 UAE Stroke Post Processing Software Market
        • 9.4.5.3.1 UAE Stroke Post Processing Software Market by Installation
        • 9.4.5.3.2 UAE Stroke Post Processing Software Market by Modality
        • 9.4.5.3.3 UAE Stroke Post Processing Software Market by Type
        • 9.4.5.3.4 UAE Stroke Post Processing Software Market by End-use
      • 9.4.5.4 Saudi Arabia Stroke Post Processing Software Market
        • 9.4.5.4.1 Saudi Arabia Stroke Post Processing Software Market by Installation
        • 9.4.5.4.2 Saudi Arabia Stroke Post Processing Software Market by Modality
        • 9.4.5.4.3 Saudi Arabia Stroke Post Processing Software Market by Type
        • 9.4.5.4.4 Saudi Arabia Stroke Post Processing Software Market by End-use
      • 9.4.5.5 South Africa Stroke Post Processing Software Market
        • 9.4.5.5.1 South Africa Stroke Post Processing Software Market by Installation
        • 9.4.5.5.2 South Africa Stroke Post Processing Software Market by Modality
        • 9.4.5.5.3 South Africa Stroke Post Processing Software Market by Type
        • 9.4.5.5.4 South Africa Stroke Post Processing Software Market by End-use
      • 9.4.5.6 Nigeria Stroke Post Processing Software Market
        • 9.4.5.6.1 Nigeria Stroke Post Processing Software Market by Installation
        • 9.4.5.6.2 Nigeria Stroke Post Processing Software Market by Modality
        • 9.4.5.6.3 Nigeria Stroke Post Processing Software Market by Type
        • 9.4.5.6.4 Nigeria Stroke Post Processing Software Market by End-use
      • 9.4.5.7 Rest of LAMEA Stroke Post Processing Software Market
        • 9.4.5.7.1 Rest of LAMEA Stroke Post Processing Software Market by Installation
        • 9.4.5.7.2 Rest of LAMEA Stroke Post Processing Software Market by Modality
        • 9.4.5.7.3 Rest of LAMEA Stroke Post Processing Software Market by Type
        • 9.4.5.7.4 Rest of LAMEA Stroke Post Processing Software Market by End-use

Chapter 10. Company Profiles

  • 10.1 Brainomix Limited
    • 10.1.1 Company Overview
    • 10.1.2 Recent strategies and developments:
      • 10.1.2.1 Product Launches and Product Expansions:
  • 10.2 Viz.ai, Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Recent strategies and developments:
      • 10.2.2.1 Partnerships, Collaborations, and Agreements:
  • 10.3 GE HealthCare Technologies, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Analysis
    • 10.3.3 Segmental and Regional Analysis
    • 10.3.4 Research & Development Expenses
    • 10.3.5 SWOT Analysis
  • 10.4 Siemens Healthineers AG (Siemens AG)
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental and Regional Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 SWOT Analysis
  • 10.5 Koninklijke Philips N.V.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Segmental and Regional Analysis
    • 10.5.4 Research & Development Expense
    • 10.5.5 Recent strategies and developments:
      • 10.5.5.1 Partnerships, Collaborations, and Agreements:
    • 10.5.6 SWOT Analysis
  • 10.6 Canon, Inc. (Canon Medical Systems Corporation)
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expenses
    • 10.6.5 SWOT Analysis
  • 10.7 Terarecon, Inc.
    • 10.7.1 Company Overview
  • 10.8 Nicolab B.V.
    • 10.8.1 Company Overview
  • 10.9 Medtronic PLC
    • 10.9.1 Company overview
    • 10.9.2 Financial Analysis
    • 10.9.3 Segmental and Regional Analysis
    • 10.9.4 Research & Development Expenses
    • 10.9.5 Recent strategies and developments:
      • 10.9.5.1 Partnerships, Collaborations, and Agreements:
    • 10.9.6 SWOT Analysis
  • 10.10. iSchemaView Inc. (RapidAI)
    • 10.10.1 Company Overview
    • 10.10.2 Recent strategies and developments:
      • 10.10.2.1 Product Launches and Product Expansions:

Chapter 11. Winning Imperatives of Stroke Post Processing Software Market

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦